MedPath

Evaluation of a Proactive Clinical Management and Early Diagnosis of Arrhythmias in Patients With Heart Failure and Non Severely Reduced Left Ventricular Function Through a Telemonitoring System

Not Applicable
Not yet recruiting
Conditions
Heart Failure
Arrhythmias, Cardiac
Interventions
Device: implantable loop recorder
Registration Number
NCT05974306
Lead Sponsor
Leonardo Calò, MD
Brief Summary

Vasco trial is a no profit, multicenter, international, prospective, randomized study designed to evaluate the clinical benefits of a remote monitoring management based on ILR vs standard practice in patients with high risk of cardiac arrhythmias, heart failure and left ventricle ejection fraction (LVEF)\> 40% .The study will enroll about 331 patients (221 in the ILR group and 110 in the in-hospital follow-up group).

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
331
Inclusion Criteria
  • Patients with heart failure, LVEF> 40% who report episodes of palpitations.
  • Over 18 years of age
  • Ability to provide informed consent for registry participation and be willing and able to comply with the protocol described evaluations
Exclusion Criteria
  • Subject who is, or is expected to be unavailable for follow-up
  • Pregnancy
  • Medical contraindications for ILR implantation
  • Patients with PMK / ICD or with Indication for ICD / PMK implantation
  • Cardiovascular events / myocardial revascularization in the previous three months
  • Patients already on oral anticoagulant treatment
  • Patients who do not want to use the telemonitoring system
  • Presence of other recognized indications to ILR (Unexplained syncope, cryptogenic stroke/TIA, Transient loss of consciousness and recurrent falls)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ILR groupimplantable loop recorderpatients implanted with an implantable loop recorder to be monitored remotely.
Primary Outcome Measures
NameTimeMethod
Evaluate the benefits of a remote monitoring management based on ILR vs standard practice in patients with high risk of cardiac arrhythmias, heart failure and LVEF> 40% in the detection of significant clinical events.2 years

Detection rate of arrhythmias that require treatment (medical or interventional)

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath